Education
About Us
Working with TipRanks
Follow Us
Resmed (RMD)
NYSE:RMD
Earnings Data
Report Date
Jan 22, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
2.72Last Year’s EPS
2.43Same Quarter Last Year
Moderate Buy
Based on 14 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflected a strong quarter for ResMed with significant revenue growth, successful product launches, and improved gross margins. However, challenges remain in the SaaS business growth and increased tax rates due to global minimum tax legislation.Company Guidance
Strong Revenue Growth
ResMed reported a 9% headline revenue growth and 8% growth on a constant currency basis for Q1 of Fiscal Year 2026, driven by strong performance across multiple regions and product categories.
Impressive U.S. and Latin America Device Sales
Device sales in the U.S., Canada, and Latin America increased by 8%, reflecting high single-digit growth, supported by new patient setups and resupply growth.
Expansion in New Product Lines
ResMed launched the AirTouch F30i mask platform, introducing the first fabric full-face masks to the market, with plans to expand to additional regions.
Gross Margin Improvement
Global supply chain efforts delivered a 280 basis points year-over-year gross margin expansion, driven by component cost improvements and manufacturing efficiencies.
Strong Cash Flow and Shareholder Returns
ResMed reported a cash flow from operations of $457 million, strong balance sheet, and returned over $238 million to shareholders through dividends and share repurchases.
RMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
RMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 30, 2025 | $252.26 | $246.88 | -2.13% |
Jul 31, 2025 | $271.37 | $278.62 | +2.67% |
Apr 23, 2025 | $213.53 | $235.10 | +10.10% |
Jan 30, 2025 | $255.98 | $234.65 | -8.33% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Resmed (RMD) report earnings?
Resmed (RMD) is schdueled to report earning on Jan 22, 2026, After Close (Confirmed).
What is Resmed (RMD) earnings time?
Resmed (RMD) earnings time is at Jan 22, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is RMD EPS forecast?
RMD EPS forecast for the fiscal quarter 2026 (Q2) is 2.72.